Haemonetics
279 hedge funds and large institutions have $5.07B invested in Haemonetics in 2018 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 94 increasing their positions, 99 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $5.92B → $5.07B (-$856M)
20% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 56
65% less call options, than puts
Call options by funds: $810K | Put options by funds: $2.29M
Holders
279
Holding in Top 10
2
Calls
$810K
Puts
$2.29M
Top Buyers
| 1 | +$80.1M | |
| 2 | +$79.7M | |
| 3 | +$42.1M | |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
+$42M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.3M |
Top Sellers
| 1 | -$65.8M | |
| 2 | -$48.1M | |
| 3 | -$46.6M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$42.9M |
| 5 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$31.9M |